Related by context. All words. (Click for frequent words.) 73 Diabetic Macular Edema DME 73 induced macular edema 73 Meets Primary Endpoint 73 Investigational Treatment 72 diabetic macular edema DME 72 acetonide FA 72 AA Amyloidosis 71 Microplasmin 71 Advanced Melanoma 71 Overactive Bladder 71 Atypical Hemolytic Uremic Syndrome 71 Phase 2b Clinical Trial 71 Wet AMD 71 Friedreich Ataxia FRDA 71 Severe Sepsis 71 Phase III Clinical Trial 71 Metastatic Colorectal Cancer 70 Ozarelix 70 Pulmonary Arterial Hypertension 70 Acute Ischemic Stroke 70 Prospective Randomized 70 Elagolix 70 Tezampanel 70 JAK Inhibitor 70 atypical Hemolytic Uremic Syndrome 70 retinal vein occlusion 70 NDA Submission 70 Initiate Clinical Trial 70 Cutaneous T 70 SinuNase TM 70 interferon gamma 1b 70 Chronic Hepatitis B 70 Dupuytren Contracture 70 Neovascular AMD 70 Oral Fingolimod 70 Prolongs Survival 69 Pivotal Phase III 69 Ophena TM 69 Complicated Skin 69 SUPPRELIN R LA 69 PEGINTRON TM 69 Central Retinal Vein 69 Bazedoxifene 69 Pivotal Trial 69 Completes Patient Enrollment 69 diarrhea predominant irritable 69 FOLOTYN ® 69 Hormone Refractory Prostate Cancer 69 Phase III Pivotal 69 invasive candidiasis 69 ALN HPN 69 Fabry Disease 69 Zenvia ™ 69 Ranolazine 69 Lubiprostone 69 delivers fluocinolone acetonide FA 69 Safinamide 69 Chronic Heart Failure 69 CTAP# Capsules 69 Benign Prostatic Hyperplasia 69 Diabetic Neuropathic Pain 69 Hepatocellular Carcinoma HCC 69 Phase 2b Trial 69 Initiates Phase III 69 Pivotal Phase 69 CYT# potent vascular disrupting 69 Clinical Trial Results 69 ARIXTRA R 69 Fondaparinux 69 ACTEMRA TM 69 Randomized Phase 69 Phase IIb Clinical Trial 69 INTEGRILIN R 69 Advanced Renal Cell 69 Alinia 68 Degarelix 68 Pooled Analysis 68 SPRYCEL ® 68 Patient Enrollment 68 herpetic keratitis 68 Vitrasert R 68 hyperphenylalaninemia HPA due 68 Golimumab 68 GABITRIL 68 MGd 68 Oral Mucositis 68 Hsp# Inhibitor 68 Romiplostim 68 Angioedema 68 Patients Treated With 68 AVONEX ® 68 Solazed TM 68 occlusion CRVO 68 Personalized Immunotherapy 68 Allergic Rhinitis 68 Hepatocellular Carcinoma 68 Catena ® 68 Valsartan 68 alvimopan 68 non metastatic osteosarcoma 68 Rilonacept 68 ILUVIEN ® 68 Acute Heart Failure 68 Pirfenidone 68 SNT MC# 68 Leber Hereditary Optic Neuropathy 68 First Patient Enrolled 68 constipation OIC 68 Controlled Trial 68 diabetic macular edema 68 dual endothelin receptor antagonist 68 HeFH 68 Phase #b/#a clinical 68 riociguat 68 Previously Treated 68 Wafer polifeprosan 68 BCG refractory carcinoma 68 IL# PE#QQR 68 relapsing remitting MS RRMS 68 Combination REOLYSIN R 68 phase IIb clinical 68 rilonacept 68 brand ciclesonide HFA 68 Myelodysplastic Syndrome MDS 68 TELINTRA 68 Lupus Nephritis 68 Tesamorelin 68 eosinophilic asthma 68 Bevacizumab 68 Bronchiectasis 68 failure ADHF 68 severe hypercholesterolemia 68 Pivotal Clinical Trial 68 Vicriviroc 68 PNP inhibitor 68 Phase IIb Trial 68 Tolvaptan 68 Iluvien ® 68 oral dual endothelin 68 MEK Inhibitor 67 First Patient Dosed 67 Hypoactive Sexual Desire Disorder 67 Myelofibrosis 67 Aflibercept 67 diabetic neuropathic pain 67 Cimzia ® certolizumab pegol 67 Chronic Myeloid Leukemia 67 LibiGel ® 67 Metastatic Melanoma 67 Novel Oral 67 thetreatment 67 Epratuzumab 67 Randomized Phase II 67 Chronic Constipation 67 secondary hyperparathyroidism 67 VIVITROL ® 67 Diabetic Neuropathy 67 Immunotherapeutic 67 ALN PCS 67 complement inhibitor eculizumab 67 oral FTY# 67 Pulmonary Arterial Hypertension PAH 67 methylnaltrexone bromide 67 posterior uveitis 67 Moxifloxacin 67 symptomatic BPH 67 Raptiva R 67 OMNARIS HFA 67 post herpetic neuralgia PHN 67 Sapacitabine 67 sorafenib tablets 67 relapsed multiple myeloma 67 oral rivaroxaban 67 Receives Orphan Drug Designation 67 Efficacy Results 67 TORISEL 67 Xcytrin R 67 Drug Candidate 67 Placebo Controlled Trial 67 Phase 2a Trial 67 either acutely decompensated 67 Chronic Sinusitis 67 Prophylactic Treatment 67 TG MV 67 Treatment Resistant 67 prokinetic agent 67 II Clinical Trial 67 FAME Study 67 Fludara ® 67 Paroxysmal Nocturnal Hemoglobinuria PNH 67 Benign Prostatic Hyperplasia BPH 67 EVIZON TM 67 Patients Treated 67 MKC# MT 67 Dapagliflozin 67 INVEGA ® 67 pseudobulbar affect PBA 67 overactive bladder syndrome 67 Demonstrates Positive 67 ABILIFY R 67 Raptiva ® 67 ATACAND 67 Relapsing Multiple Sclerosis 67 Inhalation Aerosol 67 Myelodysplastic Syndromes 67 VICTOR E3 67 Oracea TM 67 Methylnaltrexone 67 TRANSDUR ™ 67 phase III isavuconazole 67 ALN TTR 67 JAK2 Inhibitor 67 Major Depressive Disorder 67 Atopic Dermatitis 67 Long Term Efficacy 67 CRVO 67 novel VDA molecule 67 anterior uveitis 67 Entereg R 67 lexidronam injection 67 forodesine 67 Tiotropium 67 Neovascular Age Related Macular 67 hepatitis C HCV 67 Chronic Hepatitis C 67 metaglidasen 67 Keppra R 67 Kuvan R 67 Ozurdex 67 ARCOXIA 67 selective androgen receptor modulator 67 Initiates Clinical Trial 67 Primary Hypercholesterolemia 67 Fibrin Pad 67 phase IIb trial 67 adult chronic ITP 67 Ridaforolimus 67 Phase III Trial 67 Antitumor Activity 67 Ophena 67 lucinactant 67 ORENCIA R 67 YONDELIS 67 Fungal Infections 67 relapsed MM 67 Initiate Phase 67 Multicenter Randomized 66 topical non steroidal 66 Dalbavancin 66 Clinical Efficacy 66 Malignant Melanoma 66 Ischemic 66 pathologic myopia 66 Initiates Enrollment 66 Phase 2a Clinical Trial 66 familial amyloidotic polyneuropathy FAP 66 OMNARIS Nasal Spray 66 Oral Calcitonin 66 LUMINATE 66 refractory chronic lymphocytic 66 retinal vein occlusion induced 66 Myocet 66 Silodosin 66 canakinumab 66 INSPIRE Trial Phase III 66 Cethromycin 66 Alemtuzumab 66 Hypercholesterolemia 66 Amrubicin 66 relapsing multiple sclerosis 66 evaluating tivozanib 66 Cerebril TM 66 Pafuramidine 66 Renal Impairment 66 Ranibizumab 66 Actimmune ® 66 Paraplatin ® 66 phase IIa clinical 66 Cimzia TM 66 Double Blind Placebo 66 ORENCIA ® 66 Natalizumab 66 oral prodrug 66 Aliskiren 66 CIMZIA ™ 66 oxypurinol 66 Neulasta ® 66 phase IIb study 66 FASLODEX 66 Intervention Effectiveness 66 vitreoretinal disorders 66 Dose Escalation 66 systemic fungal infections 66 Relapsing Remitting Multiple Sclerosis 66 FDA APPROVES 66 Tracleer R 66 Initiates Phase II 66 Aryplase 66 Zenvia Phase III 66 THALOMID 66 refractory gout 66 metformin HCl 66 NAVISTAR R 66 histone deacetylase HDAC inhibitor 66 HCV SPRINT 66 esophageal candidiasis 66 dextromethorphan quinidine 66 metastatic castration resistant 66 Achieves Primary Endpoint 66 benign prostatic hypertrophy BPH 66 lomitapide 66 Enzyme Replacement Therapy 66 INCB# [003] 66 Combination Treatment 66 Orphan Status 66 chronic ITP patients 66 Betaferon R 66 Successfully Completes Phase 66 PROSTASCINT R 66 dextofisopam 66 ZOLINZA 66 Zorbtive TM 66 Fibrillex TM 66 placebo controlled Phase III 66 Study Evaluating 66 Glufosfamide 66 ELADUR ™ 66 Increlex R 66 FROVA 66 Hematological Malignancies 66 RAPTIVA 66 Elderly Patients 66 PROVENGE sipuleucel T 66 Subgroup Analysis 66 Myocardial Infarction Study 66 Completes Enrollment 66 Squalamine 66 Oracea ® 66 terlipressin 66 Transdermal Patch 66 Relapsed Multiple Myeloma 66 Androxal TM 66 Initiates Clinical 66 Liprotamase 66 Single Dose 66 Etanercept 66 MAGE A3 ASCI 66 Hospital Acquired Pneumonia 66 Major Depressive Disorder MDD 66 Heterozygous Familial Hypercholesterolemia 66 Phase III Clinical Trials 66 Pivotal Study 66 ST Elevation Myocardial 66 personalized cellular immunotherapy 66 MKC# MKC# PP 66 Bezielle 66 RhuDex ® 66 acute PAO 66 invasive aspergillosis 66 Azedra 66 Diabetic Foot Ulcer 66 lenalidomide Revlimid R 66 relapsed refractory multiple myeloma 66 Tarceva TM 66 AEG# 66 Irinotecan 66 gastrointestinal disorders ATI 66 QUADRAMET R 66 Pemetrexed 66 Trobalt 66 Systemic Sclerosis 66 rasagiline tablets 66 Kristalose ® lactulose 66 Cetrorelix 66 cell lymphoma CTCL 66 Phase 2b Study 66 Rheumatoid Arthritis RA 66 Resistant Hypertension 66 candesartan cilexetil 66 AeroLEF TM 66 IBS C 66 HuMax EGFr 66 Granted Orphan Drug 66 oral ridaforolimus 66 Traficet EN 66 aripiprazole Abilify 66 Mucositis 66 Nilotinib 66 Renal Cell Carcinoma 66 Treatment Experienced 66 Serious Infections 66 Palonosetron 66 sapropterin dihydrochloride Tablets 66 antibody MAb 66 Adjunctive Therapy 66 R lenalidomide 66 Decitabine 66 alpha interferons 66 PDX pralatrexate 66 virus HCV protease inhibitor 66 Nymox NX 65 Gemzar ® 65 Cellegesic 65 Randomized Clinical Trial 65 unique alkylating agent 65 Ketotransdel TM 65 Neulasta R 65 Apaziquone 65 TYGACIL 65 Randomized Double blind 65 Multiple Ascending Dose 65 atherothrombotic events 65 Juvenile Idiopathic Arthritis 65 vapreotide acetate 65 intravitreal insert 65 Granulocyte Colony Stimulating Factor 65 DDP# 65 Phase Ib Clinical Trial 65 Investigational Agent 65 Mipomersen 65 Xyrem ® 65 Venous Thromboembolism 65 opioid induced bowel dysfunction 65 catheter occlusion 65 acyclovir Lauriad R 65 Viprinex TM 65 Peginterferon 65 superficial bladder cancer 65 Gel repository corticotropin injection 65 macular edema secondary 65 ACE Inhibitors 65 Cognitive Impairment 65 Hedgehog Pathway Inhibitor 65 STRIDE PD 65 REG1 Anticoagulation System 65 pancreatic insufficiency 65 HoFH 65 TNF Tumor Necrosis Factor 65 Metastatic Prostate Cancer 65 Randomized Double Blind 65 R sorafenib tablets 65 vidofludimus 65 TEMODAL 65 CINQUIL 65 Tyrosine Kinase Inhibitor 65 OHR/AVR# 65 hereditary antithrombin deficiency 65 See CLINICAL PHARMACOLOGY 65 ThermoDox R 65 Platelet Inhibition 65 Phase IIB 65 Critical Limb Ischemia 65 Metabolic Disorder 65 Clolar ® 65 TMS Therapy 65 Serious adverse reactions 65 Castration Resistant Prostate Cancer 65 samarium Sm 65 MAA submission 65 castrate resistant prostate cancer 65 DOXIL 65 ARIXTRA 65 omega interferon 65 Lambert Eaton Myasthenic 65 Newly Diagnosed Multiple Myeloma 65 SNT-MC#/idebenone 65 Tocilizumab 65 Tamibarotene 65 recurrent glioblastoma multiforme 65 BARACLUDE R 65 PROCRIT ® 65 Acute Decompensated Heart Failure 65 Phase Ib II 65 Elotuzumab 65 HCV Protease Inhibitor 65 Refractory Hodgkin Lymphoma 65 investigational monoclonal antibody 65 CIMZIA TM certolizumab pegol 65 Antiangiogenic 65 Lenocta 65 Brentuximab Vedotin SGN 65 TRANSDUR ® 65 Dyloject TM 65 Panzem R 65 sJIA 65 Increlex ® 65 Phase Ib clinical 65 Oral Spray 65 kidney urologic 65 Monotherapy 65 generation purine nucleoside 65 INVANZ 65 Cleviprex TM clevidipine 65 deferiprone 65 pan HDAC inhibitor 65 STELARA TM 65 huC# DM4 65 Soft Tissue Sarcoma 65 Octreolin 65 octreotide implant 65 PROCRIT R 65 Renal Cell Carcinoma RCC 65 urethral bulking agent 65 proliferative diabetic retinopathy 65 alfa 2a 65 PHX# 65 Chronic Idiopathic Constipation 65 neovascular AMD 65 Diabetic Nephropathy 65 DU #b 65 BCR ABL inhibitor 65 neovascular age 65 metastatic hormone refractory 65 PAOD 65 Maribavir 65 Clinical Trial Data 65 CCX# B 65 CINTREDEKIN BESUDOTOX 65 Cardiotoxicity 65 Ranexa R 65 AGILECT R 65 Dasatinib 65 BiovaxID TM 65 Pegylated Liposomal Doxorubicin 65 Non Alcoholic Steatohepatitis 65 Adalimumab 65 reslizumab 65 ABILIFY ® 65 GW# [003] 65 rALLy 65 oropharyngeal candidiasis OPC 65 Mg Usa 65 Immune Mediated 65 Nitazoxanide 65 IMA# 65 AA amyloidosis 65 verteporfin 65 TG# [003] 65 Postmenopausal Osteoporosis 65 Retisert TM 65 PROMACTA 65 evaluating mipomersen 65 Adjuvant Treatment 65 Treating Chronic 65 Phase III Trials 65 Dual Antiplatelet Therapy 65 nasal calcitonin product 65 Well Tolerated 65 TBC# 65 Eculizumab 65 noninfectious uveitis 65 dihydrochloride Tablets 65 Pimavanserin 65 Crofelemer budesonide foam 65 TYZEKA 65 Phase Ib IIa 65 de novo kidney transplant 65 Mycophenolate Mofetil 65 hoFH 65 Entereg TM 65 cinacalcet 65 Expanded Indication 65 Chronic Lymphocytic Leukemia CLL 65 Vimpat R 65 icatibant 65 NeuroStar TMS Therapy 65 Bepreve TM 65 Tasimelteon 65 Trodusquemine MSI 65 Pegloticase 65 Nebulized 65 Functional Dyspepsia 65 homozygous familial hypercholesterolemia 65 Pralatrexate 65 Anturol TM 65 AEGR 65 PEGylated anti 65 Firazyr 65 PENTASA 65 Bosutinib 65 IV Busulfex 65 Randomized Study 65 ELACYT 65 Chronic Prostatitis 65 ADHF 65 MOVIPREP R 65 Serdolect ® 65 Vandetanib 65 Gastric Cancer 65 Replacement Therapy 65 LUX Lung 65 trastuzumab DM1 T DM1 65 arthritis PsA 65 topical gel formulation 65 targeted radiotherapeutic 65 Fast Track Status 65 Ischemic Stroke 65 Clinical Trial Evaluating 65 Kuvan sapropterin dihydrochloride 65 NYHA Class II 65 recurrent glioma 65 LEVADEX TM 65 Aviptadil 65 non splenectomized 65 Nesiritide 65 primary Restless Legs 65 NASH Huntington 65 RNAi Therapeutic 65 investigational oral inhibitor 65 PRTX 65 Bucindolol 65 Retisert 65 Amphotericin B 65 miconazole Lauriad ® 65 APEX PD 65 Demonstrates Significant 65 SHPT 65 Critical Limb Ischemia CLI 65 toenail onychomycosis 65 Warfarin Coumadin 65 Tanespimycin 65 Sevelamer 65 Acute Coronary Syndromes 65 sodium benzoate prescription 65 Temsirolimus 65 Sanvar R 65 Files IND 65 Cancer Cachexia 65 Intravitreal 64 refractory angina 64 sunitinib malate 64 PRADAXA 64 antiplatelet agent 64 eltrombopag 64 FOLFOX6 chemotherapy regimen 64 Ciclesonide 64 Noxafil 64 containing granisetron 64 OAB overactive bladder 64 Restless Legs Syndrome RLS 64 Catheter Ablation 64 rheumatoid arthritis psoriatic arthritis 64 Diabetic Patients 64 Candesartan 64 recurrent herpes labialis 64 Patient Outcomes 64 PEG SN# 64 FUSILEV ® 64 developing Bicifadine serotonin 64 reduce serum phosphate 64 XOPENEX R 64 metastatic neuroendocrine tumors 64 stage IIIB 64 Bipolar Mania 64 Carboplatin Paclitaxel 64 Anthracycline 64 acyclovir Lauriad ® 64 Romidepsin 64 Growth Hormone Deficiency 64 SPRIX ® 64 R bendamustine hydrochloride 64 Icatibant 64 corticosteroid dexamethasone 64 Receives Positive Opinion 64 Tigecycline 64 Tavocept 64 Soliris eculizumab 64 Intravitreal injections 64 acne vulgaris 64 Xyfid TM 64 PEGylated interferon beta 1a 64 partial onset seizures 64 Generalized Anxiety Disorder 64 induce orthostatic hypotension 64 Tracleer ® 64 LymphoStat B belimumab 64 retinal vein occlusion RVO 64 Chronic HCV 64 Cloretazine ® 64 Naive Patients 64 rALLy clinical trial 64 Iluvien TM 64 Avanafil 64 cutaneous T 64 Glatiramer Acetate 64 Chronic Bronchitis 64 Mg Uk 64 Durezol TM 64 NOXAFIL 64 ALN TTR# 64 Prodarsan R 64 fosbretabulin 64 Bucindolol Based 64 OvaRex ® MAb 64 PD LID 64 Peginterferon alfa 2b 64 superficial basal cell carcinoma 64 Chronic Lymphocytic Leukemia 64 Nexavar ® 64 RANK Ligand inhibitor 64 BRIM2 64 candidate XP# 64 erlotinib Tarceva ® 64 dasatinib Sprycel ® 64 Ecallantide 64 atypical hemolytic uremic syndrome 64 LEUKINE 64 Relapsed Refractory 64 Serostim ® 64 Medidur TM FA 64 Phase IIIb 64 cIAI 64 Soriatane 64 NP2 Enkephalin 64 Civacir 64 Advanced Colorectal Cancer 64 Besivance 64 Hodgkin lymphoma HL 64 cSSSI 64 Ticagrelor 64 Severe Asthma 64 Solid Tumors 64 Coronary Artery Bypass Graft 64 Treatment Naïve 64 mertansine 64 Dual Opioid 64 placebo controlled clinical 64 HYVISC R 64 Dose Ranging Study 64 Calcitonin 64 Investigational Compound 64 SJIA 64 hypoparathyroidism 64 PGL# 64 Voreloxin 64 candidemia 64 AZILECT ® 64 Cardiovascular Outcomes 64 Febuxostat 64 EFFEXOR XR 64 colesevelam HCl 64 Clofarabine 64 Clinical Outcome 64 Hycamtin ® 64 candidates Azedra 64 Ketotransdel 64 IMiDs ® compound 64 Oral Insulin 64 Multicenter Phase 64 candidates Azedra TM 64 Phase IIa Clinical Trial 64 Colorectal Cancer Patients 64 Quinamed 64 Androgen Deprivation Therapy 64 ZYBRESTAT fosbretabulin 64 Eltrombopag 64 LHON 64 CD3 monoclonal antibody 64 sapropterin dihydrochloride 64 oropharyngeal candidiasis 64 OZURDEX ® 64 REMINYL ® 64 Occlusive Disease 64 tolvaptan 64 topical NSAID 64 Demonstrates Sustained 64 Aggressive Reduction 64 ISTODAX ® 64 opioid induced constipation OIC 64 rheumatoid arthritis osteoarthritis ankylosing 64 Female Sexual Arousal 64 VISICOL R 64 FDA Accepts 64 PROMUS Element Stent 64 5 HT3 antagonist 64 HDAC Inhibitor 64 LUVENIQ 64 arsenic trioxide injection 64 Tekamlo 64 Shows Efficacy 64 Daclizumab 64 SUCCEED trial 64 cognitive impairment associated 64 Platinol ® 64 Syndrome LEMS 64 Improves Survival 64 Uterine Fibroid Embolization 64 peritumoral brain edema 64 chronic immune thrombocytopenic 64 RELOVAIR ™ 64 Dupuytren Disease 64 SEROQUEL R 64 Diabetic Retinopathy 64 JAK inhibitor 64 Vidaza azacitidine 64 Albuferon TM 64 Prostate AdenoCarcinoma Treatment 64 Inhalation Solution 64 Refractory Angina 64 Visudyne R 64 Clostridium difficile Infection 64 GTC recombinant human 64 VFEND 64 receptor tyrosine kinase inhibitor 64 CAELYX 64 idiopathic pulmonary fibrosis IPF 64 Palifosfamide 64 Perforomist ™ Inhalation Solution 64 Actemra tocilizumab 64 CoFactor 64 Potent Antiviral Activity 64 purpura ITP 64 UPLYSO 64 Trial Evaluating 64 Renal Function 64 ThermoDox ® 64 Poster Presentations 64 R Saizen R 64 Spectrum Pharmaceuticals Announces 64 CLARITY TIMI 64 Submits NDA 64 undergoing Percutaneous Coronary 64 chronic HCV infection 64 AMMONUL R 64 Filgrastim 64 Vidaza ® 64 Vaprisol 64 severe gastroparesis 64 Improves Outcomes 64 QLT# 64 unresectable HCC 64 Tibotec Therapeutics division 64 systemic juvenile idiopathic 64 Bortezomib 64 Inhaled Corticosteroids 64 Anti VEGF 64 Navelbine ® 64 ADVANCE PD 64 ospemifene 64 Retinopathy 64 Desvenlafaxine Succinate 64 Acute Coronary Syndromes ACS 64 Phase Ib study 64 Oxypurinol 64 Exacerbations 64 neurogenic orthostatic hypotension 64 Recurrent Breast Cancer 64 dirucotide MBP# 64 docetaxel Taxotere ® 64 smoldering multiple myeloma 64 MPS VI 64 orally administered inhibitor 64 ST Segment Elevation 64 AzaSite TM 64 EVIZON 64 Intravenous CP 64 antiarrhythmic drug 64 mapatumumab 64 lymphoma CTCL 64 Deferiprone 64 Thalomid ® 64 EECP R 64 Parnate 64 IND Filing 64 Itraconazole 64 miconazole MBT 64 Numoisyn Liquid 64 xanthine oxidase inhibitor 64 Neupro R 64 Acute Myocardial Infarction 64 dacarbazine DTIC 64 pioglitazone HCl 64 choroidal neovascularization 64 IOP lowering 64 Somatuline R Depot 64 chronic thromboembolic pulmonary 64 Sangamo BioSciences Announces 64 neovascular form 64 Kepivance 64 Mylan Receives Approval 64 non alcoholic steatohepatitis 64 Val HeFT 64 Advanced Solid Tumors 64 CEQ# 64 MKC# 64 FOR FURTHER INFORMATION ABOUT 64 HCV NS5B polymerase 64 Vascular Grafts 64 overactive bladder OAB 64 Omalizumab 64 Demonstrates Efficacy 64 Myelodysplastic syndromes MDS 64 C1 Inhibitor 64 Secondary Hyperparathyroidism 63 SUTENT ® 63 LUNESTA ® 63 Montelukast 63 candidate Zenvia 63 Rheumatoid Arthritis Patients 63 quetiapine fumarate 63 Pegylated Interferon 63 Ofatumumab 63 ularitide 63 primary immunodeficiency PI 63 Dyslipidemia 63 Keppra ® 63 Lu AA# 63 XYOTAX TM 63 ITAX 63 REVLIMID R 63 Bicifadine 63 LYSTEDA 63 Dabigatran etexilate 63 Azilect ® 63 aHUS 63 gastrointestinal stromal tumors GIST 63 PREZISTA r 63 Testosterone MDTS ® 63 NAGS deficiency 63 orally inhaled migraine 63 chronic idiopathic thrombocytopenic purpura 63 ARCALYST 63 BYETTA ® 63 TRISENOX ® 63 sitaxsentan 63 Unfractionated Heparin 63 haloperidol Haldol 63 fibromyalgia syndrome 63 Cloretazine 63 investigational humanized monoclonal antibody 63 acute decompensated heart 63 NATRECOR ® 63 oral salmon calcitonin 63 Previously Untreated 63 Phase #/#a trial 63 Polyneuropathy 63 pediatric malignancies 63 Thromboembolism 63 brivaracetam 63 myelodysplastic myeloproliferative diseases 63 hepatitis B HBV 63 Interferon Alpha 63 Behcet uveitis 63 Toremifene 63 prescribed proton pump 63 Faropenem 63 CCR9 antagonist 63 ASCO GI 63 Hepatitis C Virus 63 Recombinant Human 63 Severe VOD 63 cysteamine bitartrate 63 Radiofrequency Ablation 63 postoperative ileus 63 Cushing Syndrome 63 Antiviral Therapy 63 BUPHENYL 63 serotonin norepinephrine reuptake inhibitor 63 beta 1a 63 PSVT 63 Stedivaze 63 Tumor Targeting 63 metformin accumulation 63 AGGRASTAT R Injection tirofiban 63 ARCALYST ® 63 Randomized Controlled Trials 63 Epidermal Growth Factor Receptor 63 efalizumab 63 EXPAREL TM 63 ADP receptor antagonist 63 Nexavar sorafenib 63 Investigational Drug 63 Ramelteon 63 PROCRIT 63 Efficacy Trial 63 Prospective Multicenter 63 Teriparatide 63 Aneurysm Repair 63 biologic DMARD 63 ELOXATIN 63 ACZ# 63 HQK 63 oral antidiabetic medication 63 Interferon Beta 63 ENTEREG ® 63 Oral NKTR 63 First Patient Treated 63 Catheter Associated 63 anti inflammatory NSAID 63 Toxicities 63 Patient Enrolment 63 Thromboembolic 63 Demonstrate Significant 63 azelastine 63 Improve Survival 63 MoxDuo TM IR 63 CALGB # [002] 63 Survival Benefit 63 Gastrointestinal Stromal Tumors